These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15021926)

  • 21. Use of antipsychotic drugs and lithium in mania.
    Cookson J
    Br J Psychiatry Suppl; 2001 Jun; 41():s148-56. PubMed ID: 11450176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expanding pharmacopoeia for bipolar disorder.
    Mitchell PB; Malhi GS
    Annu Rev Med; 2002; 53():173-88. PubMed ID: 11818469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of bipolar disorders].
    Schmauss M; Messer T
    MMW Fortschr Med; 2009 Mar; 151(13):74-8. PubMed ID: 19504825
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment patterns in inpatients with bipolar disorder at a psychiatric university hospital over a 9-year period: focus on mood stabilizers.
    Walpoth-Niederwanger M; Kemmler G; Grunze H; Weiss U; Hörtnagl C; Strauss R; Blasko I; Hausmann A
    Int Clin Psychopharmacol; 2012 Sep; 27(5):256-66. PubMed ID: 22842799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of medication adherence in a cohort of patients with bipolar disorder.
    González-Pinto A; Reed C; Novick D; Bertsch J; Haro JM
    Pharmacopsychiatry; 2010 Nov; 43(7):263-70. PubMed ID: 20842617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany.
    Post RM; Leverich GS; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Nolen WA; Kupka R; Grunze H; Walden J; Rowe M
    Int Clin Psychopharmacol; 2011 Mar; 26(2):96-106. PubMed ID: 21178634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of bipolar disorder.
    Möller HJ; Nasrallah HA
    J Clin Psychiatry; 2003; 64 Suppl 6():9-17; discussion 28. PubMed ID: 12720475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment practices in the management of patients with bipolar disorder in France. The TEMPPO study].
    Nuss P; de Carvalho W; Blin P; Arnaud R; Filipovics A; Loze JY; Dillenschneider A
    Encephale; 2012 Feb; 38(1):75-85. PubMed ID: 22381727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mood stabilizers].
    Hatzinger M
    Ther Umsch; 2009 Jun; 66(6):413-24. PubMed ID: 19496037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder.
    Dusetzina SB; Gaynes BN; Weinberger M; Farley JF; Sleath B; Hansen RA
    Psychiatr Serv; 2011 Dec; 62(12):1443-9. PubMed ID: 22193791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bipolar disorders--how to recognize and treat them].
    Grunze H; Sasse J; Forsthoff A; Bauer M
    MMW Fortschr Med; 2004 May; 146 Spec No 2():4-6, 8. PubMed ID: 15376694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Descriptive Analysis of Factors Leading to a 1-Year Remission in Bipolar Disorder.
    Rapport D; Kaplish D; McGrady A; McGinnis R; Whearty K; Thomas M; Fine T
    J Psychiatr Pract; 2015 Sep; 21(5):351-8. PubMed ID: 26348803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Management of patients with acute manic or mixed episodes and outcome at three months].
    Azorin JM; Luquiens A; Aubrun E; Reed C; Gasquet I; Lukasiewicz M
    Encephale; 2010 Jun; 36(3):226-35. PubMed ID: 20620265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An analysis of the efficacy of treatments for bipolar depression.
    Nierenberg AA
    J Clin Psychiatry; 2008; 69 Suppl 5():4-8. PubMed ID: 19265634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between antimanic agent for treatment of classic or dysphoric mania and length of hospital stay.
    Frye MA; Altshuler LL; Szuba MP; Finch NN; Mintz J
    J Clin Psychiatry; 1996 Jan; 57(1):17-21. PubMed ID: 8543542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of lamotrigine in the management of treatment-resistant bipolar II depression: a chart review.
    Sharma V; Khan M; Corpse C
    J Affect Disord; 2008 Nov; 111(1):100-5. PubMed ID: 18314200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.